News - Teva Pharmaceutical Industries

Filter

Popular Filters

63 to 87 of 185 results

Mylan victorious in patent dispute with Teva

18-07-2013

US generic drugmaker Mylan (Nasdaq: MYL) says that Israel-based Teva Pharmaceuticals Industries (NYSE:…

GenericsMylan LaboratoriesNorth AmericaPatentsPerforomistPharmaceuticalTeva Pharmaceutical Industries

Court ruling favors Mylan in Copaxone patent dispute

17-07-2013

A US court has dismissed claims that US generic drugmaker Mylan (Nasdaq: MYL) infringed four patents…

CopaxoneGenericsMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaPatentsSandozTeva Pharmaceutical Industries

Teva and Actavis debut generic Viagra in Europe

24-06-2013

The patent on Viagra (sildenafil) expired last Friday (June 21) in the UK and some other European countries,…

ActavisEuropeGenericsMarkets & MarketingMen's HealthReproductivesildenafilTeva Pharmaceutical IndustriesViagra

FDA approves Plan B One-Step emergency contraceptive for OTC use by women of child-bearing potential

21-06-2013

The US Food and Drug Administration has approved the use of Plan B One-Step (levonorgestrel), from Israel-headquartered…

North AmericaPharmaceuticalPlan B One-StepRegulationReproductiveTeva Pharmaceutical IndustriesWomen's Health

Teva to expand respiratory business with up to $165 million acquisition of MicroDose Therapeutx

18-06-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) has entered into a definitive agreement to acquire…

Mergers & AcquisitionsMicroDose TherapeutxPharmaceuticalRespiratory and PulmonaryTeva Pharmaceutical Industries

Teva and Active Biotech to move forward with laquinimod on positive Ph IIa results in active lupus nephritis

13-06-2013

Israel's Teva Pharmaceutical Industries (NYSE: TEVA) and Swedish partner Active Biotech (OMX NORDIC:…

Active BiotechInflammatory diseaseslaquinimodNephrology and HepatologyPharmaceuticalResearchTeva Pharmaceutical Industries

Pfizer in $2.15 billion settlement from Teva and Sun for infringement of Protonix patent

12-06-2013

Global pharma behemoth Pfizer (NYSE: PFE) today (June 12) said it has reached a $2.15 billion settlement…

Gastro-intestinalsGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalProtonixSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Shire settles Intuniv patent infringement law suit against Teva concerning

03-06-2013

Ireland-headquartered drugmaker Shire (LSE: SHP) has settled its litigation against the US subsidiary…

GenericsIntunivLegalNorth AmericaPatentsPharmaceuticalShireTeva Pharmaceutical Industries

Alexza deal with Teva sets stage for Adasuve, say analysts

23-05-2013

USA-based Alexza Pharmaceuticals' (Nasdaq: ALXA) US marketing deal with Israel-headquartered Teva Pharmaceutical…

AdasuveAlexza PharmaceuticalAZ-002FinancialLicensingNeurologicalPharmaceuticalTeva Pharmaceutical Industries

Teva pays $40 million upfront to market Alexza's Adasuve in USA

09-05-2013

The US subsidiary of Israeli generics giant Teva Pharmaceuticals Industries (NYSE: TEVA) has entered…

AdasuveAlexza PharmaceuticalLicensingMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalTeva Pharmaceutical Industries

Teva 1st-qtr sales and profits decline

02-05-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) says that first-quarter 2013 net revenue dipped…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

FDA approves Raptor's Procysbi for rare genetic condition; and Plan B One-Step

01-05-2013

US drugmaker Raptor Pharmaceuticals (Nasdaq: RPTP) saw its share price rise 7.5% to $7.06 in mid-afternoon…

North AmericaPharmaceuticalPlan B One-StepProcysbiRaptor PharmaceuticalsRare diseasesRegulationReproductiveTeva Pharmaceutical IndustriesWomen's Health

US federal judge tells FDA to lift age restrictions on morning-after pill

05-04-2013

A US federal judge has ordered the Food and Drug Administration to lift age and other restrictions on…

LegalPharmaceuticalPlan BReproductiveTeva Pharmaceutical IndustriesWomen's Health

US FDA approves Teva's oral contraceptive Quartette

02-04-2013

There was good news for Israeli drugmaker Teva Pharmaceutical Industries (NYSE: TEVA) when the US Food…

North AmericaPharmaceuticalQuartetteRegulationReproductiveTeva Pharmaceutical IndustriesWomen's Health

ANN meeting highlights: Novartis' Gilenya, Lundbeck's Azilect, Orion's ODM-101, Biotie's tozadenant

21-03-2013

Among the highlights of the annual meeting of the American Academy of Neurology taking place in San Diego,…

AzilectBiotie TherapiesGilenyaLundbeckNeurologicalNovartisODM-101Orion CorpPharmaceuticalResearchTeva Pharmaceutical Industriestozadenant

Ben-Gurion University researchers and Teva develop psoriasis drug

21-03-2013

Researchers at Ben-Gurion University of the Negev (BGU), in collaboration with Israel largest drugmaker…

DermatologicalsImmunologicalsPharmaceuticalResearchTeva Pharmaceutical Industries

USPTO grants Pfizer reissue patent for Celebrex, extending term to Dec 2015

06-03-2013

Global pharma behemoth Pfizer (NYSE: PFE) said yesterday that the US Patent & Trademark Office has granted…

Anti-Arthritics/RheumaticsApotexCelebrexGenericsLupinMylan LaboratoriesNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Mundipharma's bendamustine plus rituximab doubles PFS in non-Hodgkin lymphoma and MCL patients

20-02-2013

Results from the StiL NHL-1 study published in the Lancet today (February 20) show that a first-line…

bendamustineLevactMundipharmaOncologyPharmaceuticalResearchTeva Pharmaceutical IndustriesTreanda

Gilead and Teva settle Viread patent litigation

20-02-2013

US biotech firm Gilead Sciences (Nasdaq: GILD), a global leader in the HIV/AIDS drug market, has reached…

Anti-viralsBiotechnologyGenericsGilead SciencesNorth AmericaPatentsTeva Pharmaceutical IndustriesViread

Merck & Co to pay $688 million to settle investor law suits; Teva could face $2.1 billion damages

15-02-2013

US pharma giant Merck & Co (NYSE: MRK) said yesterday that it has reached an agreement in principle with…

FinancialGenericsLegalMerck & CoPharmaceuticalProtonixTeva Pharmaceutical IndustriesVytorinZetia

63 to 87 of 185 results

Back to top